GIANT CELL ARTERITIS
Clinical trials for GIANT CELL ARTERITIS explained in plain language.
Never miss a new study
Get alerted when new GIANT CELL ARTERITIS trials appear
Sign up with your email to follow new studies for GIANT CELL ARTERITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Cheaper drug challenge: can methotrexate match expensive treatment for dangerous blood vessel disease?
Disease control OngoingThis study compares two drugs, methotrexate and tocilizumab, to control giant cell arteritis—a serious inflammatory blood vessel disease that can cause vision loss. Both aim to keep the disease in remission while reducing patients' need for long-term steroid treatments, which oft…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Trial aims to find best way to stop powerful arthritis drug, reduce costs and side effects
Disease control OngoingThis study is for people with giant cell arteritis, an inflammatory blood vessel disease, who have been in remission for at least 12 weeks while taking the drug tocilizumab. It compares two methods for stopping the medication: quitting immediately versus a slow, gradual reduction…
Matched conditions: GIANT CELL ARTERITIS
Phase: PHASE3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Scans could revolutionize how doctors spot and track painful muscle condition
Diagnosis OngoingThis study aims to find better ways to diagnose and monitor polymyalgia rheumatica (PMR), a painful muscle condition. Researchers are testing if ultrasound and PET/CT scans can accurately identify the disease and track its progress during steroid treatment. The study also investi…
Matched conditions: GIANT CELL ARTERITIS
Sponsor: Kresten Krarup Keller • Aim: Diagnosis
Last updated Mar 27, 2026 12:40 UTC